Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective

Publication Type:
Journal Article


Citation:

Park H, Rascati KL, Keith MS, Hodgkins P, Smyth M, Goldsmith D and Akehurst R. Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective. Value Health. 2011;14(8):1002-9.

 


Link to publication ⟶

⟵ Back to Search Results